Claims
- 1. A process of desalinating and/or removing ionic impurities from an aqueous solution of a contrast agent, the process comprising passing said aqueous solution through a mixed bed of ion exchange resins, comprising cation exchange resins and anion exchange resins, contained in a first treatment column (C1) having a top and a bottom, and thereafter, regenerating the mixed bed ion exchange resin by the following successive steps:(1) separating the anion exchange resins from the cation exchange resins in the first column (C1) by introducing water from the bottom of the first column (C1), to fluidize the mixed bed so that the lighter anionic resins rise above the cationic resins; (2) transferring the anionic resins from the first column (C1) to the second column having a top and bottom (C2) through a conduit connecting said first column (C1) and second column (C2), the conduit positioned at a higher level than that defined for the mixed bed and expanding the cationic resin bed in the first column (C1) to a level just below that of the transfer line; (3) regenerating the cation exchange resin directly in the first column (C1) by introducing an acid solution and in discharging the exhausted solution while maintaining the liquid level just above that of the resins; and (4) regenerating the anion exchange resin in the second column (C2) to the first column (C1) and preparing a homogeneous reconstitution of the mixed resins and fluidizing the bed by pumping water into the second column (C2) to push the bed of anionic resins through a conduit with valves and through the bottom of the first column (C1) where the bed of anionic resins rises through the fluidized bed of cationic resins mixing intimately with them.
- 2. The process of claim 1 wherein the aqueous solution contains a neutral iodinated contrast agent for radiography.
- 3. The process of claim 2 wherein the aqueous solution contains a radiographic contrast agent selected from the group consisting of iopamidol, iomeprol, iohexol, ioversol, iopentol, iopromide, ioxilan, iotriside, iobitridol, iodixanol, iofratol, iotrolan, iodecimol, iopirol, and iopiperidol.
- 4. The process of claim 1 wherein the aqueous solution contains a neutral paramagnetic contrast agent for MRI.
- 5. The process of claim 1 wherein the aqueous solution contains gadoteridol.
Priority Claims (1)
Number |
Date |
Country |
Kind |
MI96A0314 |
Feb 1996 |
IT |
|
Parent Case Info
This is a division of application Ser. No. 09/125,461, filed Aug. 19, 1998, now U.S. Pat. No. 6,187,827 which is a 371 of PCT/EP97/00670 filed Feb. 13, 1997, the entire content of which is hereby incorporated by reference in this application.
US Referenced Citations (10)
Foreign Referenced Citations (2)
Number |
Date |
Country |
27 03 044 |
Jul 1978 |
DE |
28 00 194 |
Jul 1979 |
DE |